Cancer Research Meeting Calendar EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bièche, I.
Right arrow Articles by Vidaud, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bièche, I.
Right arrow Articles by Vidaud, M.
[Cancer Research 61, 1652-1658, February 15, 2001]
© 2001 American Association for Cancer Research

Tumor Biology

Identification of CGA as a Novel Estrogen Receptor-responsive Gene in Breast Cancer: An Outstanding Candidate Marker to Predict the Response to Endocrine Therapy1

Ivan Bièche, Béatrice Parfait, Vivianne Le Doussal, Martine Olivi, Marie-Christine Rio, Rosette Lidereau and Michel Vidaud2

Laboratoire de Génétique Moléculaire–UPRES JE 2195, Faculté des Sciences Pharmaceutiques et Biologiques de Paris, F-75006 Paris [I. B., B. P., M. O., M. V.]; Laboratoire d’Oncogénétique-Institut National de la Santé et de la Recherche Médicale (INSERM) E0017 [I. B., R. L.] and Laboratoire d’Anatomo-Cytopathologie [V. L. D.], Centre René Huguenin, F-92211 St-Cloud; and Institut de Génétique et de Biologie Moléculaire et Cellulaire-INSERM U184, Université Louis Pasteur, F-67404 Illkirch Cedex [M-C. R.], France

The estrogen receptor (ER) status of breast tumors is used to identify patients who may respond to endocrine agents such as tamoxifen. However, ER status alone is not perfectly predictive, and there is a pressing need for more reliable markers of endocrine responsiveness.

Here, we identified the well-known CGA gene (coding for the {alpha} subunit of glycoprotein hormones) as a new ER{alpha}-responsive gene in human breast cancer cells. We used a real-time quantitative reverse transcription-PCR assay to quantify CGA mRNA copy numbers in a large series of breast tumors. CGA overexpression (>10 SD above the mean for normal breast tissues) was observed in 44 of 131 (33.6%) breast tumor RNAs, ranging from 20 to 16,500 times the level in normal breast tissues; the highest levels of CGA gene expression were close to those observed in placenta.

Significant links were observed between CGA gene overexpression and Scarff-Bloom-Richardson histopathological grade I+II (P = 0.015), and progesterone (P = 0.0009) and estrogen (P < 10-7) receptor positivity, which suggested that CGA is a marker of low tumor aggressiveness. We observed CGA mRNA overexpression in 44 of 90 (48.9%) ER{alpha}-positive tumors and in none of the 41 ER{alpha}-negative tumors. Immunohistochemical studies demonstrated that human chorionic gonadotropin {alpha} protein was strictly limited to ER{alpha}-positive tumor cells. Overexpression of the CGA gene was not accompanied by overexpression of the CGB gene.

Our results also suggest that CGA could be a more reliable marker than PS2 and PR for ER{alpha} functionality and, thus, for endocrine responsiveness. Moreover, the CGA marker has the added value of dichotomizing ER{alpha}-positive patients into two subgroups of similar size. Specific antibodies directed to secreted human chorionic gonadotropin {alpha} protein are commercially available, thus facilitating the future application of this marker to the clinical management of breast cancer.




This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
A. Duces, R. Karaky, D. Martel-Renoir, L. Mir, Y. Hamma-Kourbali, I. Bieche, P. Opolon, J. Delbe, J. Courty, M. Perricaudet, et al.
16-kDa fragment of pleiotrophin acts on endothelial and breast tumor cells and inhibits tumor development
Mol. Cancer Ther., September 1, 2008; 7(9): 2817 - 2827.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Landemaine, A. Jackson, A. Bellahcene, N. Rucci, S. Sin, B. M. Abad, A. Sierra, A. Boudinet, J.-M. Guinebretiere, E. Ricevuto, et al.
A Six-Gene Signature Predicting Breast Cancer Lung Metastasis
Cancer Res., August 1, 2008; 68(15): 6092 - 6099.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
F. Zemani, J.-S. Silvestre, F. Fauvel-Lafeve, A. Bruel, J. Vilar, I. Bieche, I. Laurendeau, I. Galy-Fauroux, A. M. Fischer, and C. Boisson-Vidal
Ex Vivo Priming of Endothelial Progenitor Cells With SDF-1 Before Transplantation Could Increase Their Proangiogenic Potential
Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 644 - 650.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. Fritah, C. Saucier, O. De Wever, M. Bracke, I. Bieche, R. Lidereau, C. Gespach, S. Drouot, G. Redeuilh, and M. Sabbah
Role of WISP-2/CCN5 in the Maintenance of a Differentiated and Noninvasive Phenotype in Human Breast Cancer Cells
Mol. Cell. Biol., February 1, 2008; 28(3): 1114 - 1123.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Le Stunff, A. Dechartres, V. Mariot, C. Lotton, C. Trainor, E. Miraglia Del Giudice, D. Meyre, I. Bieche, I. Laurendeau, P. Froguel, et al.
Association Analysis Indicates That a Variant GATA-Binding Site in the PIK3CB Promoter Is a Cis-Acting Expression Quantitative Trait Locus for This Gene and Attenuates Insulin Resistance in Obese Children
Diabetes, February 1, 2008; 57(2): 494 - 502.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
I. Bieche, C. Chavey, C. Andrieu, M. Busson, S. Vacher, L. Le Corre, J.-M. Guinebretiere, S. Burlinchon, R. Lidereau, and G. Lazennec
CXC chemokines located in the 4q21 region are up-regulated in breast cancer
Endocr. Relat. Cancer, December 1, 2007; 14(4): 1039 - 1052.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
D. C. Lelong, I. Bieche, E. Perez, K. Bigot, J. Leemput, I. Laurendeau, M. Vidaud, J.-P. Jais, M. Menasche, and M. Abitbol
Novel Mouse Model of Monocular Amaurosis Fugax
Stroke, December 1, 2007; 38(12): 3237 - 3244.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
S Tozlu-Kara, V Roux, C Andrieu, J Vendrell, S Vacher, V Lazar, F Spyratos, M Tubiana-Hulin, P Cohen, P Dessen, et al.
Oligonucleotide microarray analysis of estrogen receptor {alpha}-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen
J. Mol. Endocrinol., October 1, 2007; 39(4): 305 - 318.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. T. Buijs, N. V. Henriquez, P. G.M. van Overveld, G. van der Horst, I. Que, R. Schwaninger, C. Rentsch, P. ten Dijke, A.-M. Cleton-Jansen, K. Driouch, et al.
Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer
Cancer Res., September 15, 2007; 67(18): 8742 - 8751.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
D. Marot, I. Bieche, C. Aumas, S. Esselin, C. Bouquet, S. Vacher, G. Lazennec, M. Perricaudet, F. Kuttenn, R. Lidereau, et al.
High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors
Endocr. Relat. Cancer, September 1, 2007; 14(3): 691 - 702.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Pasmant, I. Laurendeau, D. Heron, M. Vidaud, D. Vidaud, and I. Bieche
Characterization of a Germ-Line Deletion, Including the Entire INK4/ARF Locus, in a Melanoma-Neural System Tumor Family: Identification of ANRIL, an Antisense Noncoding RNA Whose Expression Coclusters with ARF
Cancer Res., April 15, 2007; 67(8): 3963 - 3969.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Levy, H. Ripoche, I. Laurendeau, V. Lazar, N. Ortonne, B. Parfait, K. Leroy, J. Wechsler, I. Salmon, P. Wolkenstein, et al.
Microarray-Based Identification of Tenascin C and Tenascin XB, Genes Possibly Involved in Tumorigenesis Associated with Neurofibromatosis Type 1
Clin. Cancer Res., January 15, 2007; 13(2): 398 - 407.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
S Tozlu, I Girault, S Vacher, J Vendrell, C Andrieu, F Spyratos, P Cohen, R Lidereau, and I Bieche
Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach
Endocr. Relat. Cancer, December 1, 2006; 13(4): 1109 - 1120.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. Sevin, A. Benraiss, D. Van Dam, D. Bonnin, G. Nagels, L. Verot, I. Laurendeau, M. Vidaud, V. Gieselmann, M. Vanier, et al.
Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy
Hum. Mol. Genet., January 1, 2006; 15(1): 53 - 64.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
I. Girault, N. Rougier, C. Chesne, R. Lidereau, P. Beaune, I. Bieche, and I. de Waziers
SIMULTANEOUS MEASUREMENT OF 23 ISOFORMS FROM THE HUMAN CYTOCHROME P450 FAMILIES 1 TO 3 BY QUANTITATIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION
Drug Metab. Dispos., December 1, 2005; 33(12): 1803 - 1810.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. Arredondo, A. I. Chernyavsky, A. Karaouni, and S. A. Grando
Novel Mechanisms of Target Cell Death and Survival and of Therapeutic Action of IVIg in Pemphigus
Am. J. Pathol., December 1, 2005; 167(6): 1531 - 1544.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
D. M. Smadja, I. Bieche, G. Uzan, H. Bompais, L. Muller, C. Boisson-Vidal, M. Vidaud, M. Aiach, and P. Gaussem
PAR-1 Activation on Human Late Endothelial Progenitor Cells Enhances Angiogenesis In Vitro With Upregulation of the SDF-1/CXCR4 System
Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2321 - 2327.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. Asheuer, I. Bieche, I. Laurendeau, A. Moser, B. Hainque, M. Vidaud, and P. Aubourg
Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy
Hum. Mol. Genet., May 15, 2005; 14(10): 1293 - 1303.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M.-C. Lacroix, J. Guibourdenche, T. Fournier, I. Laurendeau, A. Igout, V. Goffin, J. Pantel, V. Tsatsaris, and D. Evain-Brion
Stimulation of Human Trophoblast Invasion by Placental Growth Hormone
Endocrinology, May 1, 2005; 146(5): 2434 - 2444.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. Arredondo, A. I. Chernyavsky, L. M. Marubio, A. L. Beaudet, D. L. Jolkovsky, K. E. Pinkerton, and S. A. Grando
Receptor-Mediated Tobacco Toxicity: Regulation of Gene Expression through {alpha}3{beta}2 Nicotinic Receptor in Oral Epithelial Cells
Am. J. Pathol., February 1, 2005; 166(2): 597 - 613.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
S. F. Fernandez, M.-H. Huang, B. A. Davidson, P. R Knight III, and J. L. Izzo Jr
Mechanisms of Angiotensin II-Mediated Decreases in Intraneuronal Ca2+ in Calcium-Loaded Stellate Ganglion Neurons
Hypertension, February 1, 2005; 45(2): 276 - 282.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. Bieche, F. Lerebours, S. Tozlu, M. Espie, M. Marty, and R. Lidereau
Molecular Profiling of Inflammatory Breast Cancer: Identification of a Poor-Prognosis Gene Expression Signature
Clin. Cancer Res., October 15, 2004; 10(20): 6789 - 6795.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Levy, I. Bieche, K. Leroy, B. Parfait, J. Wechsler, I. Laurendeau, P. Wolkenstein, M. Vidaud, and D. Vidaud
Molecular Profiles of Neurofibromatosis Type 1-Associated Plexiform Neurofibromas: Identification of a Gene Expression Signature of Poor Prognosis
Clin. Cancer Res., June 1, 2004; 10(11): 3763 - 3771.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. Alberola, A. Rodriguez, O. Francino, X. Roura, L. Rivas, and D. Andreu
Safety and Efficacy of Antimicrobial Peptides against Naturally Acquired Leishmaniasis
Antimicrob. Agents Chemother., February 1, 2004; 48(2): 641 - 643.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
I. Bieche, A. Laurent, I. Laurendeau, L. Duret, Y. Giovangrandi, J.-L. Frendo, M. Olivi, J.-L. Fausser, D. Evain-Brion, and M. Vidaud
Placenta-Specific INSL4 Expression Is Mediated by a Human Endogenous Retrovirus Element
Biol Reprod, April 1, 2003; 68(4): 1422 - 1429.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
A. Yoshida, N. Suzuki, Y. Nakano, T. Oho, M. Kawada, and T. Koga
Development of a 5' Fluorogenic Nuclease-Based Real-Time PCR Assay for Quantitative Detection of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis
J. Clin. Microbiol., February 1, 2003; 41(2): 863 - 866.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Dallol, N. F. Da Silva, P. Viacava, J. D. Minna, I. Bieche, E. R. Maher, and F. Latif
SLIT2, a Human Homologue of the Drosophila Slit2 Gene, Has Tumor Suppressor Activity and Is Frequently Inactivated in Lung and Breast Cancers
Cancer Res., October 15, 2002; 62(20): 5874 - 5880.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
S. Bretagne, R. Durand, M. Olivi, J.-F. Garin, A. Sulahian, D. Rivollet, M. Vidaud, and M. Deniau
Real-Time PCR as a New Tool for Quantifying Leishmania infantum in Liver in Infected Mice
Clin. Vaccine Immunol., July 1, 2001; 8(4): 828 - 831.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.